WA28117 Study of Tocilizumab in pcJIA
Research type
Research Study
Full title
A Phase Ib open label, multi-centre study to investigate the pharmacokinetics, pharmacodynamics, and safety of Tocilizumab following subcutaneous administration in patients with Polyarticular-Course Juvenile Idiopathic Arthritis
IRAS ID
123739
Contact name
Athimalaipet Ramanan
Contact email
Sponsor organisation
F Hoffmann-La Roche Ltd
Eudract number
2012-003486-18
REC name
North West - Greater Manchester Central Research Ethics Committee
REC reference
13/NW/0320
Date of REC Opinion
14 Jun 2013
REC opinion
Further Information Favourable Opinion